Medical technology company Medtronic's stocks surged 5 percent Tuesday in the wake of strong earnings reports, while rivals on implantable cardioverter defibrillators (ICD) market saw similar gains in the neighborhood of 4 percent, Dow... Full Article at News-Medical.net

William Hawkins, chairman and chief executive officer of Medtronic, will speak to attendees of the conference at 8 a.m. eastern time (7 a.m. central). Full Article at Freshnews.com

Last month, Medtronic (NYSE: MDT) got knocked down 3.5% on the day Boston Scientific (NYSE: BSX) lowered guidance. Normally, I'd chastise investors for painting with too broad a brush. Full Article at The Money Times

rose the most in a year after the Minneapolis-based maker of medical devices raised its earnings forecast, easing concern about slowing demand for heart devices, and said second-quarter net income jumped 59 percent to $868 million, or 78 cents a share. Full Article at Boston Globe

Net income increased to $868 million, or 78 cents a share, from $547 million, or 48 cents a share, a year earlier. Sales gained as more doctors in Japan used the company’s Endeavor drug-coated heart stent after its approval there in March. Full Article at The New York Times

By Donna Kardos Yesalavich NEW YORK—U.S. stocks fell as concern about a downward revision in third-quarter consumer spending estimates and the fallout from possible bank restrictions in China prompted investors to move away from riskier areas of the... Full Article at Wall Street Journal